Skip to Content
UW Health SMPH
American Family Children's Hospital
Erik A. Ranheim, MD, PhD close
Erik A. Ranheim, MD, PhD

For Patients

Need help selecting a doctor?
Call the Welcome Center at
(608) 821-4819 for personal assistance.

For Referring Physicians

How to refer a patient

Erik A. Ranheim, MD, PhD Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

Erik A. Ranheim, MD, PhD, earned his medical degree from the University of Minnesota and completed his residency at the Stanford University School of Medicine.



UW Health Clinics

UW Hospital and Clinics
(608) 263-8437 | (800) 323-8942 | Map

Hospital Affiliation(s)

University of Wisconsin Hospital and Clinics (primary)
Veterans Hospital - Wm. S. Middleton Memorial (secondary)

UW School of Medicine and Public Health

Department of Pathology and Laboratory Medicine

Professional Certifications and Education

Board Certification Hematopathology
Anatomic Pathology
Fellowship Stanford University School of Medicine
Residency Stanford University School of Medicine
Medical School University of Minnesota, 1996


Madison Magazine Top Docs 2014

Madison Magazine Top Docs 2012

Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.
PubMed Articles
Chang YI Damnernsawad A Allen LK Yang D Ranheim EA Young KH Zhang J Kong G Wang J Liu Y Fu HY Yang CS Guo J Song H Zhang J . Evaluation of allelic strength of human TET2 mutations and cooperation between Tet2 knockdown and oncogenic Nras mutation. Br J Haematol. 2014 Aug;166(3):461-5
[PubMed ID: 24697267]
Ranheim EA . A novel program for clinical pathology training for residents emphasizing high-impact and attending-level learning opportunities. Hum Pathol. 2014 Feb;45(2):206-12
[PubMed ID: 24196188]
Yang RK Kalogriopoulos NA Rakhmilevich AL Ranheim EA Seo S Kim K Alderson KL Gan J Reisfeld RA Gillies SD Hank JA Sondel PM . Intratumoral treatment of smaller mouse neuroblastoma tumors with a recombinant protein consisting of IL-2 linked to the hu14.18 antibody increases intratumoral CD8+ T and NK cells and improves survival. Cancer Immunol Immunother. 2013 Aug;62(8):1303-13
[PubMed ID: 23661160]
Wang J Kong G Liu Y Du J Chang YI Tey SR Zhang X Ranheim EA Saba-El-Leil MK Meloche S Damnernsawad A Zhang J Zhang J . Nras(G12D/+) promotes leukemogenesis by aberrantly regulating hematopoietic stem cell functions. Blood. 2013 Jun 27;121(26):5203-7
[PubMed ID: 23687087]
Kong G Du J Liu Y Meline B Chang YI Ranheim EA Wang J Zhang J . Notch1 gene mutations target KRAS G12D-expressing CD8+ cells and contribute to their leukemogenic transformation. J Biol Chem. 2013 Jun 21;288(25):18219-27
[PubMed ID: 23673656]
Ranheim EA . Leukocyte abnormalities associated with hyperthermia. Int J Hematol. 2013 May;97(5):545-6
[PubMed ID: 23526098]
Yang RK Kalogriopoulos NA Rakhmilevich AL Ranheim EA Seo S Kim K Alderson KL Gan J Reisfeld RA Gillies SD Hank JA Sondel PM . Intratumoral hu14.18-IL-2 (IC) induces local and systemic antitumor effects that involve both activated T and NK cells as well as enhanced IC retention. J Immunol. 2012 Sep 1;189(5):2656-64
[PubMed ID: 22844125]
Buehler D Waknitz M Rehrauer W Ranheim E Selvaggi S . Small cell variant of malignant melanoma masquerading as lymphoma on fine-needle aspiration cytology: a case report. Diagn Cytopathol. 2012 Jul;40(7):619-23
[PubMed ID: 21472865]
Wang J Liu Y Tan LX Lo JC Du J Ryu MJ Ranheim EA Zhang J . Distinct requirements of hematopoietic stem cell activity and Nras G12D signaling in different cell types during leukemogenesis. Cell Cycle. 2011 Sep 1;10(17):2836-9
[PubMed ID: 21857161]
Wang J Liu Y Li Z Wang Z Tan LX Ryu MJ Meline B Du J Young KH Ranheim E Chang Q Zhang J . Endogenous oncogenic Nras mutation initiates hematopoietic malignancies in a dose- and cell type-dependent manner. Blood. 2011 Jul 14;118(2):368-79
[PubMed ID: 21586752]
Visco C Hoeller S Malik JT Xu-Monette ZY Wiggins ML Liu J Sanger WG Liu Z Chang J Ranheim EA Gradowski JF Serrano S Wang HY Liu Q Dave S Olsen B Gascoyne RD Campo E Swerdlow SH Chan WC Tzankov A Young KH . Molecular characteristics of mantle cell lymphoma presenting with clonal plasma cell component. Am J Surg Pathol. 2011 Feb;35(2):177-89
[PubMed ID: 21263238]
Mathias JR Dodd ME Walters KB Yoo SK Ranheim EA Huttenlocher A . Characterization of zebrafish larval inflammatory macrophages. Dev Comp Immunol. 2009 Nov;33(11):1212-7
[PubMed ID: 19619578]
Wu QL Buhtoiarov IN Sondel PM Rakhmilevich AL Ranheim EA . Tumoricidal effects of activated macrophages in a mouse model of chronic lymphocytic leukemia. J Immunol. 2009 Jun 1;182(11):6771-8
[PubMed ID: 19454672]
Wu QL Zierold C Ranheim EA . Dysregulation of Frizzled 6 is a critical component of B-cell leukemogenesis in a mouse model of chronic lymphocytic leukemia. Blood. 2009 Mar 26;113(13):3031-9
[PubMed ID: 19179304]
Buhtoiarov IN Rakhmilevich AL Lanier LL Ranheim EA Sondel PM . Naive mouse macrophages become activated following recognition of L5178Y lymphoma cells via concurrent ligation of CD40, NKG2D, and CD18 molecules. J Immunol. 2009 Feb 15;182(4):1940-53
[PubMed ID: 19201847]
Kim YC Clark RJ Ranheim EA Alexander CM . Wnt1 expression induces short-range and long-range cell recruitments that modify mammary tumor development and are not induced by a cell-autonomous beta-catenin effector. Cancer Res. 2008 Dec 15;68(24):10145-53
[PubMed ID: 19074881]
Ranheim EA Tarbell KV Krogsgaard M Mallet-Designe V Teyton L McDevitt HO Weissman IL . Selection of aberrant class II restricted CD8+ T cells in NOD mice expressing a glutamic acid decarboxylase (GAD)65-specific T cell receptor transgene. Autoimmunity. 2004 Dec;37(8):555-67
[PubMed ID: 15763918]